Showing results (271-280 of 498) with videos related to

Sort By:
Pageof 50
Cancer Research and Treatment|July 29, 2021
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System LymphomaSang Eun Yoon, Yeon Jeong Kim, Joon Ho Shim, et al.
Experimental and Therapeutic Medicine|September 21, 2012
Schedule-dependent synergistic effect of rituximab on methotrexate chemotherapy against lymphoma of the central nervous systemJuyoun Jin, Kyeung Min Joo, Yoonhee Nam, et al.
Oncotarget|May 19, 2015
Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal typeSeungbok Lee, Ha Young Park, So Young Kang, et al.
Haematologica|April 10, 2025
Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 studyTae Min Kim, Nehal J Lakhani, Jacob Soumerai, et al.
Haematologica|January 28, 2017
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II studyVincent Ribrag, Won Seog Kim, Reda Bouabdallah, et al.
Clinical Lymphoma & Myeloma|January 12, 2008
Clinicopathologic features and treatment outcomes in malignant lymphoma of pediatric and young adult patients in Korea: comparison of korean all-ages group and Western younger age groupIn Gyu Hwang, Keon Hee Yoo, Soo Hyun Lee, et al.
Japanese Journal of Clinical Oncology|November 19, 2003
Measuring response in solid tumors: comparison of RECIST and WHO response criteriaJoon Oh Park, Soon Il Lee, Seo Young Song, et al.
Human Pathology|April 20, 2010
Enteropathy-associated T-cell lymphoma--a clinicopathologic and array comparative genomic hybridization studyYoung Hyeh Ko, Sivasundaram Karnan, Kyeong Mee Kim, et al.
Japanese Journal of Clinical Oncology|November 19, 2003
Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancerSeo-Young Song, Won Seog Kim, Kihyun Kim, et al.
Cancers|August 13, 2020
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 TrialHo-Young Yhim, Dok Hyun Yoon, Seok Jin Kim, et al.
Pageof 50